Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2015-12-18

New recommendations to minimise risks of the rare brain infection PML and a type of skin cancer with Gilenya

View source ↗

Summary

EMA offers new recommendations to minimize risks of progressive multifocal leukoencephalopathy (PML) and a type of skin cancer associated with Gilenya (fingolim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GILENYA (FINGOLIMOD HCL)